Blade Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Blade Therapeutics's estimated annual revenue is currently $6M per year.
- Blade Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Blade Therapeutics has 39 Employees.
- Blade Therapeutics grew their employee count by -13% last year.
Blade Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | President & CEO | Reveal Email/Phone |
2 | Head Human Resources | Reveal Email/Phone |
3 | SVP Investor Relations | Reveal Email/Phone |
4 | Chief Technology Officer | Reveal Email/Phone |
5 | Managing Director | Reveal Email/Phone |
6 | EVP- Business Development | Reveal Email/Phone |
Blade Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.7M | 24 | -8% | N/A | N/A |
What Is Blade Therapeutics?
Blade Therapeutics is a private biopharmaceutical company founded on a commitment to revolutionize the treatment of debilitating, incurable fibrotic diseases that impact millions of people worldwide. The Company is an expert in novel biological pathways – including autotaxin / LPA and calpain biology – that are foundational to cell and tissue damage responses leading to fibrosis. We are advancing a robust pipeline of potential first- and best-in-class investigational therapies for diseases of lung, liver and heart fibrosis, as well as neuro-degenerative diseases. This includes multiple small-molecule direct inhibitors of autotaxin / LPA and dimeric calpains that offer distinct but complementary anti-fibrotic mechanisms. Since its founding in 2015, Blade has raised approximately $90 million, including investments from Deerfield Management, MPM Capital, Pfizer Ventures, One Ventures, Osage University Partners and pharma strategic investments from Bristol-Myers Squibb and Novartis Institutes for Biomedical Research. The Company has assembled critical leadership expertise supplemented by a world-class network of scientific, pharmaceutical and clinical advisors to enable efficient and successful drug development.
keywords:N/AN/A
Total Funding
39
Number of Employees
$6M
Revenue (est)
-13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Blade Therapeutics News
Blade Therapeutics, Inc. is a biopharmaceutical company focused on developing cutting-edge treatments for debilitating, incurable fibrotic and...
Blade Therapeutics, Inc. is a biopharmaceutical company focused on developing cutting-edge treatments for debilitating, incurable fibrotic and...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $6M | 39 | -15% | N/A |
#2 | $8.4M | 39 | -64% | N/A |
#3 | $9.8M | 39 | 3% | $86M |
#4 | $5.4M | 40 | 5% | $44.7M |
#5 | $8M | 41 | -25% | N/A |